Network origin in Paul Bevan first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 17 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Paul Bevan via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| FRESENIUS SE & CO. KGAA | Medical Specialties | Corporate Officer/Principal Director/Board Member | |
| 2INVEST AG | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member | |
| BASF SE | Electrical Products | Corporate Officer/Principal Corporate Officer/Principal | |
UCB Pharma GmbH
 UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| ZOGENIX, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Mundipharma International Ltd.
 Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| STADA ARZNEIMITTEL | Pharmaceuticals: Major | Director/Board Member | |
| REALTECH AG | Miscellaneous Commercial Services | Chairman | |
Ratiopharm GmbH
 Ratiopharm GmbH Pharmaceuticals: MajorHealth Technology ratiopharm GmbH engages in the production and distribution of generic drugs and pharmaceutical products. It offers pain relievers, nasal sprays, bronchial drops, as well as medicines for treating high blood pressure, cancer, pulmonary arterial hypertension, human immunodeficiency virus infection and acquired immune deficiency syndrome. The company was founded in 1973 and is headquartered in Ulm, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
| Technische Universität München | College/University | Doctorate Degree | |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Graduate Degree | |
| Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Corporate Officer/Principal | |
| University of Mannheim | College/University | Doctorate Degree Undergraduate Degree | |
| Technische Universität Braunschweig | College/University | Doctorate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Graduate Degree Doctorate Degree | |
LTS LOHMANN Therapie-Systeme AG
 LTS LOHMANN Therapie-Systeme AG Pharmaceuticals: MajorHealth Technology LTS LOHMANN Therapie-Systeme AG manufactures transdermal therapeutic systems and oral thin films. The firm's product range encompasses oral active ingredient films, nicotine patches, and pharmaceutical drugs in dosage forms. Its service areas cover clinical trials, laboratory testing, and research and development projects. The company was founded in 1984 and is headquartered in Andernach, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Chairman | |
Aenova Holding GmbH
 Aenova Holding GmbH Medical DistributorsDistribution Services Aenova Holding GmbH provides supplies to the pharmaceutical and healthcare industries. The firm develops, produces, and markets solid dosage products such as soft and hard capsules, tablets, film-coated tablets, and effervescent tablets. Its services include production, supply chain management, packaging, support and analytics. The company was founded in 2008 and is headquartered in Starnberg, Germany. | Medical Distributors | Chief Executive Officer | |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Investment Managers | Private Equity Investor Founder Chief Executive Officer | |
| Febit, Inc. | Director/Board Member Chairman | ||
Rottendorf Pharma GmbH
 Rottendorf Pharma GmbH Pharmaceuticals: MajorHealth Technology Part of Rottendorf-Stiftung, Rottendorf Pharma GmbH is a German company that engages in manufacturing, packaging, developing formulations and analytical methods for solid oral dosage forms for the pharmaceutical industry. The company is based in Ennigerloh, Germany. The company was founded in 1928 by Andreas J. Rottendorf. The CEO is Stephan Fleck. | Pharmaceuticals: Major | Director/Board Member | |
BIO Deutschland
 BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB
 RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB Miscellaneous Commercial ServicesCommercial Services RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB is a law firm based in Mannheim, Germany. The German company has a unique perspective on the legal world and operates differently from traditional law firms. The private company's description emphasizes its distinctiveness and alternative approach to legal services. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
APEIRON Biologics AG
 APEIRON Biologics AG BiotechnologyHealth Technology APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria. | Biotechnology | Chief Executive Officer | |
PhRMA Foundation
 PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services The PhRMA Foundation is an organization that provides awards and support to individuals pursuing higher education. The non-profit company is based in Washington. The organization's 2022 annual report highlights their activities and showcases their 2022 awardees. | Miscellaneous Commercial Services | Director/Board Member | |
| dievini Verwaltungs GmbH | Chief Executive Officer Chief Executive Officer Chief Executive Officer | ||
Molecular Health GmbH
 Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Miscellaneous Commercial Services | Chief Executive Officer Chairman Director/Board Member | |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Chairman Director/Board Member Director/Board Member | |
Wilex, Inc.
 Wilex, Inc. Medical/Nursing ServicesHealth Services Part of Nuclea Biotechnologies, Inc., Wilex, Inc. develops medical diagnostic tests. The company is based in Cambridge, MA. The CEOs of the company are Thomas Borcholte, Olaf G. Wilhelm. Wilex was acquired by Nuclea Biotechnologies, Inc. from Heidelberg Pharma AG on September 06, 2013. | Medical/Nursing Services | Chief Executive Officer Director of Finance/CFO Chief Executive Officer | |
Novaliq GmbH
 Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Medical Specialties | Chairman Director/Board Member | |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Biotechnology | Director/Board Member Director/Board Member | |
Heidelberg Pharma Research GmbH
 Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German company that engages in researching biotechnology. The company is based in Ladenburg, Germany. The company was founded in 2011. Andreas Pahl has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
| MAS Consult AG | Director/Board Member | ||
Bormioli Pharma SpA
 Bormioli Pharma SpA Miscellaneous ManufacturingProducer Manufacturing Bormioli Pharma SpA designs and manufactures pharmaceutical packaging solutions. It offers packaging for dual-chamber system, oral, parenteral, ophthalmic and nasal drugs. The company was founded in 2017 and is headquartered in Parma, Italy. | Miscellaneous Manufacturing | Director/Board Member | |
| IMMATICS N.V. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Frankfurt University Medical School | College/University | Corporate Officer/Principal | |
| invIOs Holding AG | Chief Executive Officer | ||
| Biotechnologie-Industrie-Organisation Austria | Chief Executive Officer | ||
febit holding GmbH
 febit holding GmbH Medical/Nursing ServicesHealth Services febit holding GmbH engages in the design and development of technologies used for DNA analysis. It specializes in technologies with applications in genomic research, RNA expression profiling, and other diagnostic and molecular biology fields. The company was founded by Markus Beier, Ramon Gueimil, Peer F. Staehler, Matthias Scheffler, and Cord F. Stähler in 2005 and is headquartered in Heidelberg, Germany. | Medical/Nursing Services | Director/Board Member Chairman |
Statistics
International
| Germany | 39 |
| United States | 7 |
| Austria | 4 |
| Switzerland | 2 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 21 |
| Commercial Services | 10 |
| Consumer Services | 8 |
| Finance | 3 |
| Producer Manufacturing | 3 |
Operational
| Director/Board Member | 102 |
| Chairman | 46 |
| Chief Executive Officer | 38 |
| Corporate Officer/Principal | 37 |
| Doctorate Degree | 12 |
Most connected contacts
| Insiders | |
|---|---|
| Christof Hettich | 40 |
| Friedrich von Bohlen und Halbach | 36 |
| David Ebsworth | 26 |
| Mathias Hothum | 19 |
| Iris Löw-Friedrich | 15 |
| Alexandra Goll | 14 |
| Peter Llewellyn-Davies | 14 |
| Andreas Krebs | 13 |
| Birgit Kudlek | 11 |
| Thomas Borcholte | 11 |
| Martin Bürmann | 10 |
| Jan Schmidt-Brand | 9 |
| Andreas Pahl | 9 |
| Olaf G. Wilhelm | 4 |
| Charlotte Lohmann | 4 |
- Stock Market
- Insiders
- Paul Bevan
- Company connections
